Inventor · Tustin, CA, US

Joan-En Chang-Lin

29Patents
11h-index
21Co-inventors
71Inventor score

Filing activity: Apr 30, 2004 → Sep 10, 2018

Most-cited inventions

PatentTitleAreaCited byStatus
US8512738B2 Biodegradable intravitreal tyrosine kinase implants Human Necessities 58 Active
US8409607B2 Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods Emerging Cross-Sectional Technologies 53 Active
US7771742B2 Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods Emerging Cross-Sectional Technologies 37 Active
US7931909B2 Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates Human Necessities 34 Active
US8571802B2 Method for determining optimum intraocular locations for drug delivery systems Human Necessities 28 Active
US8299118B2 Enhanced bimatoprost ophthalmic solution Human Necessities 25 Active
US7851504B2 Enhanced bimatoprost ophthalmic solution Human Necessities 22 Active
US8278353B2 Enhanced bimatoprost ophthalmic solution Human Necessities 15 Active
US8309605B2 Enhanced bimatoprost ophthalmic solution Human Necessities 15 Active
US8933120B2 Enhanced bimatoprost ophthalmic solution Human Necessities 13 Active
US8569367B2 Ophthalmic compositions and methods for treating eyes Human Necessities 13 Active
US8338479B2 Enhanced bimatoprost ophthalmic solution Human Necessities 8 Active
US8586630B2 Enhanced bimatoprost ophthalmic solution Human Necessities 7 Active
US8524777B2 Enhanced bimatoprost ophthalmic solution Human Necessities 6 Active
US8569370B2 Ophthalmic compositions and methods for treating eyes Human Necessities 5 Active
US8729125B2 Ophthalmic compositions and methods for treating eyes Human Necessities 5 Active
US9241918B2 Enhanced bimatoprost ophthalmic solution Human Necessities 5 Active
US8772338B2 Enhanced bimatoprost ophthalmic solution Human Necessities 4 Active
US7714024B2 Compositions and methods for the intraocular transport of therapeutic agents Human Necessities 4 Active
US9155716B2 Enhanced bimatoprost ophthalmic solution Human Necessities 4 Active
US8933127B2 Enhanced bimatoprost ophthalmic solution Human Necessities 3 Active
US9233070B2 Biodegradable intravitreal tyrosine kinase implants Human Necessities 3 Active
US8404267B2 Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods Emerging Cross-Sectional Technologies 2 Active
US10076492B2 Biodegradable intravitreal tyrosine kinase implants Human Necessities 2 Active
US8637571B2 Compositions and methods for the intraocular transport of therapeutic agents Human Necessities 1 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.